May 1, 2024

Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To evaluate whether time targets for Canadian Agency for Drugs and Technologies in Health (CADTH) reimbursement reviews and pan-Canadian Pharmaceutical Alliance (pCPA) price negotiations are being achieved for oncology drugs.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Rawson et al. (Wed,) studied this question.

synapsesocial.com/papers/68e6c1b7b6db6435876407de https://doi.org/https://doi.org/10.2147/ceor.s462872

Preguntar a la IA

Me gusta

Guardar